Healthy volunteers study
Healthy volunteers study
As part of our psilocybin therapy development programme, we partnered with the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London to run a study with healthy volunteers. The study was a phase I, double-blind placebo-controlled study with 89 healthy volunteers, aged between 18 and 65 years.
Initial results from the study were presented at the ACNP 2019 annual meeting (see poster). The results showed that psilocybin was well-tolerated when administered to healthy adult volunteers with support from specially trained therapists (click here to read our press release).
Further results from the study were presented at the ASCP 2021 annual meeting (see poster). The results showed that COMP360 psilocybin had no clinically-relevant negative effect on cognitive function, when administered to healthy adult volunteers with support from specially trained therapists (click here to read our press release).
